Sfoglia per AUTORE
SCHIRRIPA M
Collezione ASL Biella

  

Items : 3

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study. in Targeted oncology / Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1.

2024
ASL Biella
AOU Città della Salute di Torino

Stefano C; Rimassa L; Casadei-Gardini A; Antonuzzo L; Vivaldi C; Rizzato MD; Foti S; De Braud F; De Rosa A; Ratti F; Aldrighetti L; Fornaro L; Niger M; Zanuso V; Garattini SK; Satolli MA; Rossari F; Brandi G; Brunetti O; Leone F; Pirrone C; Diana A; Toma I; Pretta A; Lorenzo A; Landriscina M; Gusmaroli E; Bergamo F; Balsano R; et alii...

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes. in The oncologist / Oncologist. 2020 Jun;25(6):481-487. doi: 10.1634/theoncologist.2019-0611. Epub 2020 Jan 22.

2020
ASL Biella

Fassan M; Zagonel V; Lonardi S; Nguyen A; Schirripa M; Sanborn JZ; Dei Tos AP; Golovato J; Rugge M; Salmaso R; Munari G; Zapata L; Sottoriva A; Valeri N; Bonetti LR; Maddalena G; Cascinu S; Spallanzani A; Leone F; Lombardi P; Filippi R; Prete AA; Biason P; Intini R; Depetris I; Loupakis F;

Lactate dehydrogenase (LDH) levels to predict benefit from the continuation of bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Subgroup analysis of the randomized BEBYP study in Journal of Clinical Oncology

2016
ASL Biella

Marmorino F; Cremolini C; Loupakis F; Barbara C; Dargenio F; Miraglio E; Masi G; Salvatore L; Marcucci L; Antonuzzo L; Chiara S; Banzi C; Schirripa M; Amoroso D; Bonetti A; Martignetti A; Paris M; Boni L; Tomcikova D; Falcone A;